Johnson & Johnson Innovation Opens Applications for Three Funding Opportunities to Fuel Your Life Science Business
By Sarah Ellinwood
June 5, 2023
It’s no secret that the current state of the economy has made it difficult for life science companies, particularly startups, to raise capital. If you’re looking for funding this summer, be sure to check out these upcoming opportunities from Johnson & Johnson Innovation.
BLUE KNIGHT™ QuickPitch: Activating for the Future
The COVID-19 pandemic exemplified the importance of disease outbreak preparedness. And while COVID-19 has waned over the past year, this doesn’t mean we can let our guard down for preparing for future disease outbreaks.
To that end, Johnson & Johnson Innovation, together with the Biomedical Advanced Research and Development Authority (BARDA), is proud to launch the BLUE KNIGHT™ QuickPitch: Activating for the Future.
Innovators are invited to submit potentially ground-breaking ideas or technologies that aim to enhance preparedness toward future known and unknown health threats, including emerging pathogens.
Awards: Up to 10 innovator(s) with the best potential solution will earn the opportunity to pitch to a panel of industry experts including Johnson & Johnson and BARDA leadership at JLABS @ Washington, DC on August 29. In addition, applicants may be invited to join BLUE KNIGHT™ through residency at the hub at JLABS @ Washington, DC, based on their applications and/or presentations.
Deadline: June 23, 2023
More Info & Application
Advancing Oncology InnoVAtion QuickFire Challenge
Virginia is on the rise as a major life science hub, particularly with the recent announcement of $66.7M in state grants to help the Commonwealth thrive. Among the projects proposed include plans for an advanced laboratory incubator in the City of Roanoke to develop new biotech companies across southwestern Virginia.
Johnson & Johnson Innovation, in collaboration Carilion Clinic Innovation, Verge Alliance, and Virginia Tech Corporate Research Center (VTCRC), is proud to invite innovators from around the globe are invited to submit potential solutions aiming to transform patient outcomes in oncology in adult populations with potential applications in pediatric oncology.
Awards: Innovator(s) with the best potential solution can receive grant funding from a total pool of $300,000*, VTCRC residency for one year, which includes one lab bench and workstation, access to the global Johnson & Johnson Innovation – JLABS (JLABS) network, and mentorship from experts across The Johnson & Johnson Family of Companies
Deadline: Aug 11, 2023
More Info & Application
Inflammatory Bowel Disease QuickFire Challenge
About 1.3 million people are living with inflammatory bowel disease (IBD) in the United States, and data suggests that adults with IBD are more likely to have other chronic conditions than those without IBD. Despite this prevalence, there is limited data about the epidemiology, disease characteristics and outcomes, particularly in BIPOC (Black, Indigenous, and People of Color) populations.
Johnson & Johnson Innovation and Janssen Research & Development have launched the Inflammatory Bowel Disease QuickFire Challenge: Innovating for Health Equity. US-based innovators are invited to submit data-driven research methodologies, tools or technologies that aim to better understand the manifestations of IBD and determinants of health disparity in diverse racial and ethnic communities.
Awards: Innovator(s) with the best potential solution will receive grant funding from a total pool of up to $250,000, access to the global Johnson & Johnson Innovation – JLABS network, and mentorship from experts across The Johnson & Johnson Family of Companies for one year.
Deadline: July 20, 2023
More Info & Application
If you have questions about these or other funding opportunities, please reach out to Scott T. Shepherd, Innovation Activation Manager, Johnson & Johnson Innovation – JLABS @ Washington, DC
- About the Author
- Latest Posts
Sarah Ellinwood is BioBuzz’s Managing Editor. A scientist by training and a science communicator at heart, Sarah specializes in making complex concepts understandable, engaging, and exciting. She received her Ph.D. in molecular and cellular biology with a focus in infectious disease immunology from the University of Maryland and is passionate about all things related to scicomm, peer mentorship, and women in STEM.
